Engaging education helps to improve knowledge and skills retention by nurses at every stage of their career. Learn how to gamify information in clinical settings as well as classrooms--and how the same techniques can also assist patient learning.

Guest: Megan ­­­Webber, MSN, RN, NPD-BC, CMSRN

PCNA Patient Education Resources: https://pcna.net/resources/patient-education/

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Sharing stories about the work nurses do carries weight with decision-makers. Guest Kristan Langdon, DNP, APRN, ANP-C, CPHQ, emphasizes the importance of communicating your first-hand experiences in compelling conversations at the local, regional, state, and national level.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A diagnosis of HCM impacts mental as well as physical health. Hear from Lora Peppard, PhD, DNP, PMHNP-BC on interventions that nurses can use to support patients with HCM and lead to improved quality of life, adherence, and long-term health outcomes.

Related resources:

HCM & Mental Health: https://www.4hcm.org/hcm-and-mental-health

American Psychiatric Nurses Association connection paradigm

Spirituality wellness assessments

Mattering Science: Zach Mercurio

Flourishing Science: Christie Bethel

PCNA resources on HCM for providers and patients

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Utilizing shared decision-making in the diagnosis and management of hypertrophic cardiomyopathy can support positive outcomes for patients, family members and caregivers. Guests Kim Hecker, BSN, BA, RN, and Jillian Thorne, describe the process, and the impacts across all stages of the patient journey.

References and related resources:

2024 AHA/ACC Guideline for the Management of HCM

Twice the Heart Foundation: https://www.instagram.com/twicetheheartfoundation/

PCNA resources on HCM for providers and patients

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Review the latest clinical guidelines on LDL-C reduction, especially for your patients with diabetes. Guest Susan Halli Demeter, DNP, CNP, NP, also reflects on how engaging patients in shared decision-making aids in treatment adherence and identifies potential barriers to address, including polypharmacy, access, and other issues.

References and Related Resources:

PCNA Lipid resources for providers and patients

PCNA Diabetes resources for providers and patients

CARDS trial

IMPROVE-IT trial

FOURIER trial

ODYSSEY trial

VESALIUS-CV trial

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Earlier ASCVD risk reduction is better--particularly for patients with diabetes. Guest Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, discusses the importance of reviewing family history, and shares strategies for decision-making in primary and secondary risk reduction strategies asuch as lowering LDL-C, blood glucose, hypertension, smoking, and other factors.

Related Resources:

PCNA Lipid resources for providers and patients

PCNA Diabetes resources for providers and patients

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

PREVENT Risk Calculator

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

What can we be doing to reduce LDL-C to decrease the risk for cardiovascular disease, particularly in our patients with diabetes? Learn from Margo B. Minissian, PhD, RN, ACNP-BC, NEA-BC, FAAN about the role of high blood sugar in cardiovascular disease, effective strategies for lowering LDL-C, and the importance of early treatment.

Related Resources:

PCNA Lipid Resources for Providers and Patients

PCNA Diabetes Resources for Providers and Patients

2018 AHA/ACC Guideline on the Management of Blood Cholesterol

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

IVUS Regression Trials: REVERSAL (2004), ASTEROID (2006); SATURN (2011); GLAGOV (2016); PRECISE-IVUS(2015); JAPAN-ACS (2009)

COURAGE trial

VESALIUS-CV trial

Pleiotropic effects of statins

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease in the US. Guest James Norton, BSN, RN, shares the hallmark signs and symptoms, and describes how shared decision-making in the care of patients with HCM from diverse populations.

Related resources:

AHA HCM sudden cardiac death risk calculator: https://professional.heart.org/en/guidelines-and-statements/hcm-risk-calculator

Clinical Course & Management of HCM: https://www.nejm.org/doi/full/10.1056/NEJMra1710575

HCM Sudden Cardiac Death Calculator: https://professional.heart.org/en/guidelines-and-statements/hcm-risk-calculator

2024 AHA/ACC Guideline for the Management of HCM: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001250

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.